Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The global Erectile Dysfunction Drugs market is projected to reach US$ 7335.2 million by 2030 from an estimated US$ 5171.1 million in 2024, at a CAGR of 6.0% during 2024 and 2030.
North America is the largest Erectile Dysfunction Drugs market with about 39% market share. Europe is follower, accounting for about 30% market share.
The key players are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO. etc. Top 3 companies occupied about 57% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction Drugs.
The Erectile Dysfunction Drugs market size, estimations, and forecasts are provided in terms of sales volume (M Pill) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Erectile Dysfunction Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erectile Dysfunction Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
麻豆原创 Segmentation
By Company
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.
Segment by Type
Sildenafil
Tadalafil
Others
Segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Erectile Dysfunction Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Erectile Dysfunction Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Erectile Dysfunction Drugs sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Erectile Dysfunction Drugs Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Erectile Dysfunction Drugs 麻豆原创 Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 麻豆原创 by Application
1.3.1 Global Erectile Dysfunction Drugs 麻豆原创 Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce (B2B)
1.3.6 E-Commerce (B2C)
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Erectile Dysfunction Drugs 麻豆原创 Size Estimates and Forecasts
2.1.1 Global Erectile Dysfunction Drugs Revenue 2019-2030
2.1.2 Global Erectile Dysfunction Drugs Sales 2019-2030
2.2 Erectile Dysfunction Drugs 麻豆原创 Size by Region: 2023 Versus 2030
2.3 Erectile Dysfunction Drugs Sales by Region (2019-2030)
2.3.1 Global Erectile Dysfunction Drugs Sales by Region: 2019-2024
2.3.2 Global Erectile Dysfunction Drugs Sales Forecast by Region (2025-2030)
2.3.3 Global Erectile Dysfunction Drugs Sales 麻豆原创 Share by Region (2019-2030)
2.4 Erectile Dysfunction Drugs 麻豆原创 Estimates and Projections by Region (2025-2030)
2.4.1 Global Erectile Dysfunction Drugs Revenue by Region: 2019-2024
2.4.2 Global Erectile Dysfunction Drugs Revenue Forecast by Region (2025-2030)
2.4.3 Global Erectile Dysfunction Drugs Revenue 麻豆原创 Share by Region (2019-2030)
3 Global Erectile Dysfunction Drugs by Manufacturers
3.1 Global Top Erectile Dysfunction Drugs Manufacturers by Sales
3.1.1 Global Erectile Dysfunction Drugs Sales by Manufacturer (2019-2024)
3.1.2 Global Erectile Dysfunction Drugs Sales 麻豆原创 Share by Manufacturer (2019-2024)
3.2 Global Top Erectile Dysfunction Drugs Manufacturers by Revenue
3.2.1 Global Erectile Dysfunction Drugs Revenue by Manufacturer (2019-2024)
3.2.2 Global Erectile Dysfunction Drugs Revenue Share by Manufacturer (2019-2024)
3.3 Global Erectile Dysfunction Drugs Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Erectile Dysfunction Drugs Manufacturers Covered: Ranking by Revenue
3.4.2 Global Erectile Dysfunction Drugs 麻豆原创 Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Erectile Dysfunction Drugs 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Erectile Dysfunction Drugs Manufacturing Base Distribution, Product Type
3.5.1 Erectile Dysfunction Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Erectile Dysfunction Drugs Product Type
3.5.3 Date of International Manufacturers Enter into Erectile Dysfunction Drugs 麻豆原创
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Eli Lilly
4.1.1 Eli Lilly Company Information
4.1.2 Eli Lilly Description, Business Overview
4.1.3 Eli Lilly Erectile Dysfunction Drugs Products Offered
4.1.4 Eli Lilly Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
4.1.5 Eli Lilly Erectile Dysfunction Drugs Sales by Product in 2023
4.1.6 Eli Lilly Erectile Dysfunction Drugs Sales by Application in 2023
4.1.7 Eli Lilly Erectile Dysfunction Drugs Sales by Geographic Area in 2023
4.1.8 Eli Lilly Recent Developments
4.2 Pfizer
4.2.1 Pfizer Company Information
4.2.2 Pfizer Description, Business Overview
4.2.3 Pfizer Erectile Dysfunction Drugs Products Offered
4.2.4 Pfizer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
4.2.5 Pfizer Erectile Dysfunction Drugs Sales by Product in 2023
4.2.6 Pfizer Erectile Dysfunction Drugs Sales by Application in 2023
4.2.7 Pfizer Erectile Dysfunction Drugs Sales by Geographic Area in 2023
4.2.8 Pfizer Recent Developments
4.3 Bayer
4.3.1 Bayer Company Information
4.3.2 Bayer Description, Business Overview
4.3.3 Bayer Erectile Dysfunction Drugs Products Offered
4.3.4 Bayer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Bayer Erectile Dysfunction Drugs Sales by Product in 2023
4.3.6 Bayer Erectile Dysfunction Drugs Sales by Application in 2023
4.3.7 Bayer Erectile Dysfunction Drugs Sales by Geographic Area in 2023
4.3.8 Bayer Recent Developments
4.4 BaiYunShan General Factory
4.4.1 BaiYunShan General Factory Company Information
4.4.2 BaiYunShan General Factory Description, Business Overview
4.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Products Offered
4.4.4 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
4.4.5 BaiYunShan General Factory Erectile Dysfunction Drugs Sales by Product in 2023
4.4.6 BaiYunShan General Factory Erectile Dysfunction Drugs Sales by Application in 2023
4.4.7 BaiYunShan General Factory Erectile Dysfunction Drugs Sales by Geographic Area in 2023
4.4.8 BaiYunShan General Factory Recent Developments
4.5 S.K. Chemicals
4.5.1 S.K. Chemicals Company Information
4.5.2 S.K. Chemicals Description, Business Overview
4.5.3 S.K. Chemicals Erectile Dysfunction Drugs Products Offered
4.5.4 S.K. Chemicals Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
4.5.5 S.K. Chemicals Erectile Dysfunction Drugs Sales by Product in 2023
4.5.6 S.K. Chemicals Erectile Dysfunction Drugs Sales by Application in 2023
4.5.7 S.K. Chemicals Erectile Dysfunction Drugs Sales by Geographic Area in 2023
4.5.8 S.K. Chemicals Recent Developments
4.6 Teva Pharma
4.6.1 Teva Pharma Company Information
4.6.2 Teva Pharma Description, Business Overview
4.6.3 Teva Pharma Erectile Dysfunction Drugs Products Offered
4.6.4 Teva Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
4.6.5 Teva Pharma Erectile Dysfunction Drugs Sales by Product in 2023
4.6.6 Teva Pharma Erectile Dysfunction Drugs Sales by Application in 2023
4.6.7 Teva Pharma Erectile Dysfunction Drugs Sales by Geographic Area in 2023
4.6.8 Teva Pharma Recent Development
4.7 Dong-A ST
4.7.1 Dong-A ST Company Information
4.7.2 Dong-A ST Description, Business Overview
4.7.3 Dong-A ST Erectile Dysfunction Drugs Products Offered
4.7.4 Dong-A ST Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
4.7.5 Dong-A ST Erectile Dysfunction Drugs Sales by Product in 2023
4.7.6 Dong-A ST Erectile Dysfunction Drugs Sales by Application in 2023
4.7.7 Dong-A ST Erectile Dysfunction Drugs Sales by Geographic Area in 2023
4.7.8 Dong-A ST Recent Development
4.8 Metuchen Pharma
4.8.1 Metuchen Pharma Company Information
4.8.2 Metuchen Pharma Description, Business Overview
4.8.3 Metuchen Pharma Erectile Dysfunction Drugs Products Offered
4.8.4 Metuchen Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
4.8.5 Metuchen Pharma Erectile Dysfunction Drugs Sales by Product in 2023
4.8.6 Metuchen Pharma Erectile Dysfunction Drugs Sales by Application in 2023
4.8.7 Metuchen Pharma Erectile Dysfunction Drugs Sales by Geographic Area in 2023
4.8.8 Metuchen Pharma Recent Development
4.9 Seoul Pharma
4.9.1 Seoul Pharma Company Information
4.9.2 Seoul Pharma Description, Business Overview
4.9.3 Seoul Pharma Erectile Dysfunction Drugs Products Offered
4.9.4 Seoul Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
4.9.5 Seoul Pharma Erectile Dysfunction Drugs Sales by Product in 2023
4.9.6 Seoul Pharma Erectile Dysfunction Drugs Sales by Application in 2023
4.9.7 Seoul Pharma Erectile Dysfunction Drugs Sales by Geographic Area in 2023
4.9.8 Seoul Pharma Recent Development
4.10 CSBIO.
4.10.1 CSBIO. Company Information
4.10.2 CSBIO. Description, Business Overview
4.10.3 CSBIO. Erectile Dysfunction Drugs Products Offered
4.10.4 CSBIO. Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
4.10.5 CSBIO. Erectile Dysfunction Drugs Sales by Product in 2023
4.10.6 CSBIO. Erectile Dysfunction Drugs Sales by Application in 2023
4.10.7 CSBIO. Erectile Dysfunction Drugs Sales by Geographic Area in 2023
4.10.8 CSBIO. Recent Development
5 Breakdown Data by Type
5.1 Global Erectile Dysfunction Drugs Sales by Type (2019-2030)
5.1.1 Global Erectile Dysfunction Drugs Sales by Type (2019-2024)
5.1.2 Global Erectile Dysfunction Drugs Sales Forecast by Type (2025-2030)
5.1.3 Global Erectile Dysfunction Drugs Sales 麻豆原创 Share by Type (2019-2030)
5.2 Global Erectile Dysfunction Drugs Revenue Forecast by Type (2019-2030)
5.2.1 Global Erectile Dysfunction Drugs Revenue by Type (2019-2024)
5.2.2 Global Erectile Dysfunction Drugs Revenue Forecast by Type (2025-2030)
5.2.3 Global Erectile Dysfunction Drugs Revenue 麻豆原创 Share by Type (2019-2030)
5.3 Erectile Dysfunction Drugs Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Erectile Dysfunction Drugs Sales by Application (2019-2030)
6.1.1 Global Erectile Dysfunction Drugs Sales by Application (2019-2024)
6.1.2 Global Erectile Dysfunction Drugs Sales Forecast by Application (2025-2030)
6.1.3 Global Erectile Dysfunction Drugs Sales 麻豆原创 Share by Application (2019-2030)
6.2 Global Erectile Dysfunction Drugs Revenue Forecast by Application (2019-2030)
6.2.1 Global Erectile Dysfunction Drugs Revenue by Application (2019-2024)
6.2.2 Global Erectile Dysfunction Drugs Revenue Forecast by Application (2025-2030)
6.2.3 Global Erectile Dysfunction Drugs Revenue 麻豆原创 Share by Application (2019-2030)
6.3 Erectile Dysfunction Drugs Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Erectile Dysfunction Drugs 麻豆原创 Size YoY Growth 2019-2030
7.2 North America Erectile Dysfunction Drugs 麻豆原创 Facts & Figures by Country
7.2.1 North America Erectile Dysfunction Drugs Sales by Country (2019-2030)
7.2.2 North America Erectile Dysfunction Drugs Revenue by Country (2019-2030)
7.3 North America Erectile Dysfunction Drugs Sales by Type (2019-2024)
7.4 North America Erectile Dysfunction Drugs Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Erectile Dysfunction Drugs 麻豆原创 Size YoY Growth 2019-2030
8.2 Asia-Pacific Erectile Dysfunction Drugs 麻豆原创 Facts & Figures by Region
8.2.1 Asia-Pacific Erectile Dysfunction Drugs Sales by Region (2019-2030)
8.2.2 Asia-Pacific Erectile Dysfunction Drugs Revenue by Region (2019-2030)
8.3 Asia-Pacific Erectile Dysfunction Drugs Sales by Type (2019-2024)
8.4 Asia-Pacific Erectile Dysfunction Drugs Sales by Application (2019-2024)
9 Europe
9.1 Europe Erectile Dysfunction Drugs 麻豆原创 Size YoY Growth 2019-2030
9.2 Europe Erectile Dysfunction Drugs 麻豆原创 Facts & Figures by Country
9.2.1 Europe Erectile Dysfunction Drugs Sales by Country (2019-2030)
9.2.2 Europe Erectile Dysfunction Drugs Revenue by Country (2019-2030)
9.3 Europe Erectile Dysfunction Drugs Sales by Type (2019-2024)
9.4 Europe Erectile Dysfunction Drugs Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Erectile Dysfunction Drugs 麻豆原创 Size YoY Growth 2019-2030
10.2 Latin America Erectile Dysfunction Drugs 麻豆原创 Facts & Figures by Country
10.2.1 Latin America Erectile Dysfunction Drugs Sales by Country (2019-2030)
10.2.2 Latin America Erectile Dysfunction Drugs Revenue by Country (2019-2030)
10.3 Latin America Erectile Dysfunction Drugs Sales by Type (2019-2024)
10.4 Latin America Erectile Dysfunction Drugs Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Erectile Dysfunction Drugs 麻豆原创 Size YoY Growth 2019-2030
11.2 Middle East and Africa Erectile Dysfunction Drugs 麻豆原创 Facts & Figures by Country
11.2.1 Middle East and Africa Erectile Dysfunction Drugs Sales by Country (2019-2030)
11.2.2 Middle East and Africa Erectile Dysfunction Drugs Revenue by Country (2019-2030)
11.3 Middle East and Africa Erectile Dysfunction Drugs Sales by Type (2019-2024)
11.4 Middle East and Africa Erectile Dysfunction Drugs Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Erectile Dysfunction Drugs Supply Chain Analysis
12.2 Erectile Dysfunction Drugs Key Raw Materials and Upstream Suppliers
12.3 Erectile Dysfunction Drugs Clients Analysis
12.4 Erectile Dysfunction Drugs Sales Channel and Sales Model Analysis
12.4.1 Erectile Dysfunction Drugs Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Erectile Dysfunction Drugs Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Erectile Dysfunction Drugs Distributors
13 麻豆原创 Dynamics
13.1 Erectile Dysfunction Drugs Industry Trends
13.2 Erectile Dysfunction Drugs 麻豆原创 Drivers
13.3 Erectile Dysfunction Drugs 麻豆原创 Challenges
13.4 Erectile Dysfunction Drugs 麻豆原创 Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.
听
听
*If Applicable.